NCT00102414View on ClinicalTrials.gov

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

356

Participants

Timeline

Start Date

September 30, 1999

Study Completion Date

November 30, 2004

Conditions

Ovarian Cancer

Interventions

DRUG

Gemcitabine

All Listed Sponsors

lead

AGO Study Group

OTHER

NCT00102414 - Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer | Biotech Hunter | Biotech Hunter